Summary of Key Points from Conference Call Records Industry Overview 1. PCB (Printed Circuit Board) - The PCB sector has shown weak performance since Q4 of last year, primarily due to divergent market views on orthogonal backplane solutions, with some believing they may be replaced by copper cables/CPO or delayed until 2028. However, the orthogonal backplane is currently progressing steadily and is expected to enter mass production in H2 2027. Leading companies are experiencing stock price stagnation due to these divergences, highlighting their cost-effectiveness. Recommended companies include Dongshan Precision, Shenghong Technology, and Huidian Co. [1] - The CoWoP (Chip on Wafer on PCB) solution has stronger certainty, can reduce costs, improve efficiency, and bypass the shortage of substrate capacity. The value per square meter of PCB may increase several times, potentially reaching tenfold, with product launches expected by the end of 2027 and full implementation in 2028. Recommended companies in this direction include Pengding Holdings, Shennan Circuit, and Xinsong Technology. [1] 2. Storage - Contract prices remain in an upward cycle despite fluctuations in spot prices. Module companies are expected to see explosive Q1 performance, with Jiangbolong and Demingli realizing low-priced inventory. Recommended design companies include Zhaoyi Innovation (with a profit expectation of 6 billion) and Puran Co., Beijing Junzheng, and Hengshuo Co. [2] - Demand for memory modules is driven by AI servers and general servers, with recommendations for Lanke Technology (long-term profit of 10 billion) and Jucheng Co. (long-term profit of 1.5 billion). [2] 3. Communication - The recent decline in optical modules is related to the pullback of US tech stocks and speculation around CPO concepts. However, industry sources (such as Coherent and Xuchuang) indicate that CPO's potential to replace optical modules in ScaleOut scenarios is low, suggesting that short-term speculation may be excessive. [2] - North American cloud service providers have exceeded capital expenditure guidance for 2026 (620 billion, up 65% year-on-year), indicating potential accelerated demand for optical modules in 2027. Key upcoming catalysts include Nvidia's quarterly report (February 26), GTC conference (March), and OFC exhibition (NPO product showcase). Recommended companies include Zhongji Xuchuang, Xinyisheng, and Dongshan Precision. [2] - For copper connections as a Plan B alternative to orthogonal backplanes, companies to watch include Luxshare Precision, Wokai Nuclear Materials, and Huiju Technology (with potential for stock doubling). [2] - The price of scattered fiber has surged in the short term (from 25 to 50 yuan), but the low willingness of operators to raise prices raises doubts about long-term sustainability. [2] 4. Computing - Domestic computing resources are in short supply, with the recent downtime of Qianwen highlighting the scarcity of AI foundational resources. The demand for CPUs is expected to rise due to increased usage of agents compared to chatbots. Recommended companies include Haiguang Information (benefiting from both CPU and GPU), Cambrian (leading domestic AI chip manufacturer), and Tianshu Zhixin (expected to accelerate integration with leading players). [2] - Cloud infrastructure resources are expected to benefit from price increases, with recommendations for Kingsoft Cloud, Wangsu Technology, and Fourth Paradigm. [2] - In the AI application sector, the recent drop in overseas software and restructuring of SaaS business models may lead to a narrative reversal with the launch of native agent products in Q3 2026. Companies to watch include Alibaba for 2C entry reconstruction and third-party AI agents like TaxFriend, Zhongkong Technology, and Dingjie Smart. [2] 5. Media - Tencent has faced a decline due to market concerns over potential tax increases on internet platforms, although there is no space for increased game value-added tax. The company remains recommended despite rumors of Q4 earnings downgrades, maintaining a PE ratio of 15 times, which still offers value. [3] - The download situation for the Yuanbao app remains stable, and Tencent's AI capabilities may be closing the gap with larger competitors. [3] - In gaming, companies with upcoming catalysts such as Giant Network and Perfect World are recommended for short-term focus, while Century Huatong and Kaiying Network are suggested for medium to long-term attention due to expected catalysts. [3] - Tencent's establishment of a separate AI comic app is beneficial for the production side, which is entering a period of profitability. Recommendations include Kuaishou, Huanrui, and Rongxin. [3] 6. Pharmaceuticals - Attention is drawn to the update of the essential drug catalog, which may accelerate progress. [4] - The probability of inclusion in the essential drug catalog is high for unique products, with several specific products from companies like Jichuan Pharmaceutical and Panlong Pharmaceutical being highlighted. [4] - Emphasis on the global competitiveness of the innovative drug industry chain, with a focus on new-generation ADCs, IOs, small nucleic acids, and CGT. Recommended companies include Kanghong, Yingen, Yunding, and Chengdu Xian Dao. [4] - The brain-computer interface theme is noted, with a potential showcase of non-invasive products during the Spring Festival and a semi-invasive product approval for Borui Kang in March. [4] - Recommendations include Meihua Medical, Dongwei Semiconductor, and Sanbo Brain Science. [5] - The surgical robot sector is expected to see comprehensive implementation of charging policies before August, with overseas orders doubling and maintaining high growth in 2027. Key types include laparoscopic and orthopedic robots, with strong overseas performance for laparoscopic robots. Recommended companies include MicroPort, Jingfeng Medical, Tianzhihang, and Sanyou Medical. [6]

Investment Rating - The report maintains a "Buy" rating for the medical services industry, suggesting a positive outlook for investment opportunities in this sector [10][64]. Core Insights - The medical services sector has shown resilience, with a recent increase in the sector's PE ratio to 34.43X and PB ratio to 3.49X, indicating a positive trend in valuation metrics [4][29]. - The approval of internet medical first diagnosis trials in Beijing marks a significant regulatory breakthrough, potentially accelerating the online medical service process and providing new market opportunities for private medical institutions [5][62][63]. - The report highlights the importance of digital regulation and standardization in enhancing service capabilities for private medical institutions, particularly in consumer healthcare sectors like pediatrics and dermatology [5][62]. Summary by Sections Industry Performance - The pharmaceutical and biological sector increased by 0.14%, ranking 15th among 31 primary industries, outperforming the Shanghai Composite Index by 1.47 percentage points [2][12]. - The medical services sub-sector reported a 1.31% increase, closing at 6827.17 points, with a year-to-date performance of 41.41% [24][27]. Company Performance - Top-performing companies in the medical services sector include Meidisi (+18.0%), Tongce Medical (+8.1%), and Nuosige (+5.7%), while underperformers include Haoyuan Pharmaceutical (-6.2%) and Baicheng Pharmaceutical (-4.5%) [3][27]. Valuation Metrics - The medical services sector's PE ratio has increased by 0.56X from the previous week, while the PB ratio has risen by 0.06X, indicating a strengthening in market confidence [4][29]. Investment Recommendations - The report suggests focusing on high-growth areas such as ADC CDMO and peptide CDMO in the pharmaceutical outsourcing sector, as well as companies like WuXi AppTec and Haoyuan Pharmaceutical [10][64]. - It also recommends monitoring private medical service providers with compliance experience, such as Aier Eye Hospital, as they are expected to benefit from the evolving regulatory landscape [5][64].

行 业 297 机械设备 2026 年 02 月 08 日 研 究 中央政治局集体学习聚焦脑机接口等未来产业技术，解 码脑机接口产业发展内核 投资要点： 认清产业本质，脑机接口是超复杂系统工程 行 业 定 期 报 告 中央政治局第二十四次集体学习将脑机接口列为未来产业重点方 向，在脑机接口明确为未来产业重点方向之后，一个更值得深入讨论 的问题是：脑机接口究竟是一类什么样的产业形态——其并非单一技 术领域，而是兼具技术高度耦合、产业链与跨学科跨度大的超复杂系 统工程，由神经科学研究、硬件制造、算法研发等多子系统构成，各 环节动态闭环且相互制约。我国当前发展该产业存在明显短板，核心 软硬件存在外部依赖形成的 "软硬分离" 问题，同时脑数据标准不 统一、算力调度分散等基础设施薄弱问题，也制约了技术迭代与产业 发展。 聚焦系统构建，多维度夯实产业发展底座 我国脑机接口产业已进入底座构建期，发展的关键并非单点技术 突破，而是完成系统整合的跃迁。需先明确国家级技术路线图并建设 脑数据国家库等共享基础设施，再建立科研、产业、区域多层级协同 机制，同时完善覆盖全生命周期的监管体系并参与国际标准制定，更 要通过高校交叉学科布局 ...

西工大团队在植入式脑机接口 \r\n\r\n 来源：国海金贝壳 脑机接口作为融合生命科学、信息技术与 人工智能 的颠覆性技术，正成为大国角逐未来产业主导权的 战略高地。 \r\n\r\n 研究领域取得新进展 \r\n\r\n 从意念操控 机械 臂、神经语言翻译，到帕金森、瘫痪等神经疾病精准诊疗，植入式脑机接口正从科幻 构想走向现实应用。 \r\n\r\n 据中国日报网消息，近日，西北工业大学常洪龙、吉博文科研团队宣布，其研发的三维锥形碳基软性大 脑皮层电极阵列取得关键突破，成功破解长期制约行业发展的脑组织损伤、信号衰减、生物相容性差等 核心难题，同时完成国际首次太空环境技术验证，为脑机接口的临床转化与航天应用开辟全新路径，彰 显我国在微机电系统（MEMS）领域的顶尖创新实力。 \r\n\r\n 针对传统微创植入式皮层电极柔软度低、与脑组织接触效果差、长期植入金属易腐蚀甚至溶解失效等关 键问题，西工大团队历经多年潜心攻关，创新研发出三维锥形碳基软性大脑皮层电极阵列。 \r\n\r\n 动物实验结果表明，该电极采集信号更加稳定，关键性能较传统金属电极提升数百倍，能够长期安全地 进行刺激调控，并可在超高场核磁共振检 ...

Core Viewpoint - The article highlights significant advancements in brain-machine interface (BMI) technology in China, showcasing breakthroughs in flexible electrode arrays and clinical applications, indicating a growing investment interest and market potential in this field [1][4][6]. Group 1: Technological Breakthroughs - A research team from Northwestern Polytechnical University has developed a three-dimensional conical carbon-based flexible cortical electrode array, addressing key issues such as brain tissue damage and poor biocompatibility, and achieving international space environment technology validation [1]. - The electrode shows hundreds of times improvement in key performance metrics compared to traditional metal electrodes, ensuring long-term safety and stability for clinical applications [1]. - The article notes that 2025 is referred to as the "year of the brain-machine interface" in China, with multiple clinical trials and innovations being reported [2]. Group 2: Investment and Market Growth - Investment enthusiasm in the BMI sector has surged, with 24 financing events recorded from January to November 2025, marking a 30% year-on-year increase, and total financing exceeding 10 billion yuan over the past five years [4]. - The "14th Five-Year Plan" has identified brain-machine interfaces as one of six future industries, indicating a strategic focus on this technology as a new engine for economic growth [4]. - The BMI market in China was valued at 3.2 billion yuan in 2024, with an 18.8% year-on-year growth, projected to reach 5.58 billion yuan by 2027, reflecting a 20% growth rate [6]. Group 3: Clinical Applications and Innovations - Ming Vision Brain Machine Technology has introduced an implantable BMI visual reconstruction system, offering new possibilities for visually impaired patients [5]. - The second invasive BMI clinical trial has achieved significant progress, transitioning from 2D screen control to 3D physical world interaction [5]. - Shanghai Brain Tiger Technology has successfully completed the first clinical trial of a fully implanted, wireless, and functional BMI product, emphasizing the technology's potential to connect life and hope [5]. Group 4: Stock Market Performance - Several BMI-related stocks have experienced significant declines, with 14 stocks showing over a 20% drop from their highs, including HaiGe Communication and PuLiTe [6][7]. - In terms of profit forecasts for 2025, nine BMI-related stocks are expected to see net profit growth, with notable increases for companies like BeiLu Pharmaceutical and LePu Medical [8].

三博脑科（301293.SZ）2月6日在投资者互动平台表示，三博脑科于2012年及2020年全国首家引入 ROSA手术设备及其二代手术设备ROSA ONE行SEEG电极植入，公司SEEG电极植入手术量及有效率均 处于全国先进水平。公司主要的收入来源为下属院区提供的医疗服务业务，神经外科手术量实现趋势增 长。 （文章来源：每日经济新闻） 每经AI快讯，有投资者在投资者互动平台提问：请问三博脑科的癫痫电极植入技术是否已经成熟，并 且成为公司主要的现金流？ ...

Core Insights - The report highlights the strong performance of the domestic financial market, with the Shanghai Composite Index closing at 4102.2, up by 0.85% [4] - It emphasizes the ongoing sector rotation, with funds shifting from high-tech stocks to consumer and new energy sectors due to increasing uncertainties as the Spring Festival approaches [10] Macroeconomic News Summary - The Central Committee and State Council issued opinions on advancing rural revitalization [6] - The central bank aims to support key areas such as expanding domestic demand and technological innovation in the 2026 credit market [6] - The Ministry of Industry and Information Technology is focused on advancing key technologies in AI and manufacturing [6] Industry Updates - NAND flash memory prices are expected to rise over 40% quarter-on-quarter in Q1 2026, with related stocks including Zhaoyi Innovation and Northern Huachuang [7] - The first "Traditional Chinese Medicine Brain-Computer Interface" has been established, with related stocks including Sanbo Brain Science and Innovative Medical [7] - In January, 36 Chinese companies made it to the global top 100 mobile game publishers by revenue, with related stocks including Century Huatong and Kaiying Network [7] Company Focus - Rongda Photoelectric plans to complete its first high-end photoresist production line by the second half of 2026 [8] - Huagong Technology is focused on manufacturing engines and precision components, with ongoing customer certifications for its communication modules [8] - Xingye Silver Tin's Vice President increased his shareholding, reflecting confidence in the company's long-term value [8] - Qianli Technology's subsidiary has achieved L3-level intelligent driving capabilities and has applied for testing licenses [8] Market Review and Outlook - The market showed strong performance with the Shanghai index recovering above 4100 points, while trading volume decreased by 633 billion compared to the previous day [9] - Sectors such as coal, transportation services, real estate, and construction materials saw significant gains, while technology sectors faced declines [9] - The report suggests maintaining a moderate position in investments, focusing on cyclical stocks as the market enters an earnings-driven phase [10]

【中泰医药】脑机动态定期更新 近期部分重要进展： 1、赵继宗院士牵头制定的《植入式脑机接口临床应用路径管理中国专家共识（2026 版）》正式发布，推动 iBCI 临床转化科学、安全、有序发展； 2、民政部印发《关于进一步推进民政科技创新的指导意见》，《意见》要求广泛应用人形机器人、脑机接口、人 工智能等前沿技术，开展失能失智预防和抗衰老、生活照料和康复护理、精神慰藉和社会参与促进、安全风险监 测和紧急救援、老年宜居 仅需3分钟就能迅速打开血脑屏障，与血脑屏障未开放的脑组织相比，药物浓度可以平均提高8倍，并且在治疗后6 小时关闭血脑屏障，疗效和安全性均优于国际相关报道； 7、Ybrain招募三星电子和VUNO前高管，推广基于tDCS和脑电图技术的非口服抗抑郁药、打造AI心理健康生态系 统； 8、韩国数字医疗企业Neofect宣布与韩德联合财团合作，共同推进脑机接口商业化，项目将耗时36个月（2025.9- 2028.8）研发基于脑神经控制的脑卒中患者上肢辅助与康复机器人系统。 【中泰医药】脑机动态定期更新 近期部分重要进展： 1、赵继宗院士牵头制定的《植入式脑机接口临床应用路径管理中国专家共识（2026 版）》 ...

Core Viewpoint - The ChiNext Medical Index (970082) closed at 3876.07 points on February 3, with a gain of 2.37% and a trading volume of 13.236 billion yuan, indicating positive market sentiment in the medical sector [1]. Group 1: Index Performance - The ChiNext Medical Index saw 49 constituent stocks rise, with NuoSiGe leading the gains at 8.76% [1]. - The index's turnover rate was 1.71%, reflecting moderate trading activity [1]. Group 2: Top Constituents - The top ten constituents of the ChiNext Medical Index include: - YuanEr Eye Hospital (sz300015) with a weight of 9.18% and a latest price of 11.04 yuan, up 1.28% [1]. - MaiRui Medical (sz300760) with a weight of 8.95% and a latest price of 188.15 yuan, up 0.56% [1]. - TaiGe Medical (sz300347) with a weight of 8.52% and a latest price of 63.20 yuan, up 4.97% [1]. - KangLong HuaCheng (sz300759) with a weight of 7.18% and a latest price of 29.61 yuan, up 2.10% [1]. - LePu Medical (sz300003) with a weight of 4.96% and a latest price of 17.83 yuan, up 1.89% [1]. - New Industry (sz300832) with a weight of 4.73% and a latest price of 54.50 yuan, up 2.60% [1]. - AiMeiKe (sz300896) with a weight of 4.49% and a latest price of 147.57 yuan, up 4.56% [1]. - YingKe Medical (sz300677) with a weight of 4.14% and a latest price of 40.55 yuan, up 1.38% [1]. - FuRui Medical (sz300049) with a weight of 3.55% and a latest price of 67.33 yuan, up 1.45% [1]. - HuaDa Gene (sz300676) with a weight of 3.15% and a latest price of 50.30 yuan, up 2.57% [1]. Group 3: Capital Flow - The net inflow of main funds into the ChiNext Medical Index constituents totaled 145 million yuan, while retail investors experienced a net outflow of 106 million yuan [1]. - The detailed capital flow indicates that TaiGe Medical had a main fund net inflow of 10.514 million yuan, while retail investors had a net outflow of 18.28% [2].

脑机接口硬件设备主要包括脑电采集设备、脑机接口芯片，以及电源、采集器、同步器、刺激器、解码 器等设备零部件。其中，脑机接口硬件设备最为核心的便是用于脑电信号采集或神经反馈的脑电采集设 备(即电极)，以及用于脑电信号处理的脑机接口芯片。脑机接口芯片分为侵入式和非侵入式两大类，其 中侵入式脑机接口芯片要求远高于非侵入式。在侵入式脑机接口中，芯片的主要功能包括数据读出和信 号激励，此外为了保证方便和外界沟通还需要使用无线传输。 | 数据或出 | 数据读出主要是指脑机接口从脑部该取特定区域的信号,并且在芯片上做一系列初步处理,包括滚波 | | --- | --- | | | 等。具体多少信号处理在芯片上做,多少传输到片外完成则取决于整个芯片的设计考量。例如,对于 | | | 一些需要做快速反应的脑机接口芯片(例如检测颠縮并快速介入),则需要把尽可能多的处理在芯片 | | | 上实现,以满足延迟的需求。此外,通常经过芯片处理的信号比起原始信号的数据量会小,因此脑机 | | | 接口片上处理部分和无线数据传输部分是一对重要的权衡对象;片上处理越简单,则相关电路逻辑面 | | | 积和功耗越小,但是需要无线传输的数据量就越 ...